Form 4: Phreesia Director Exercises Options and Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Phreesia director Michael Weintraub exercised stock options and sold shares on December 2, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

  • On December 2, 2024, Michael Weintraub, a director at Phreesia, Inc., exercised stock options to acquire 15,152 shares at a price of $2.03 per share.
  • Concurrently, Mr. Weintraub sold 15,152 shares at a weighted average price of $21.0116 per share, with individual sales ranging from $20.58 to $21.385.
  • These transactions were executed under a pre-established Rule 10b5-1 trading plan.
  • Following these transactions, Mr. Weintraub directly owns 242,827 shares of Phreesia common stock.
  • He also has indirect ownership of 91,045 shares through the Michael Weintraub 2023 Qualified Annuity Trust and 6,703 shares through the Weintraub Family 2017 Irrevocable Trust.
  • Mr. Weintraub disclaims beneficial ownership of the shares held in the trusts except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing detailing insider transactions. It doesn't indicate any positive or negative sentiment, just routine activity.

Industry Context

This is a routine filing related to insider transactions and is common for publicly traded companies. The use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading.

Comparison to Industry Standards

  • The use of a 10b5-1 trading plan is a common practice among executives and directors of publicly traded companies to manage their stock transactions and avoid potential insider trading issues.
  • The reported transactions are similar to those seen in other companies where executives exercise stock options and sell shares for personal financial management.
  • The price range of the share sales is within the typical fluctuations observed in the market for similar companies.

Stakeholder Impact

  • The transactions may have a minor impact on the stock price due to the volume of shares sold, but this is likely to be minimal given the pre-planned nature of the sales.

Key Dates

DateDescription
12/02/2024Date of the stock option exercise and share sale transactions.
12/04/2024Date the Form 4 was signed.
12/18/2024Expiration date of the stock options.

Keywords

Phreesia, Michael Weintraub, stock options, share sale, Form 4, 10b5-1 plan, insider trading, beneficial ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.